Hormonal therapy in cancer of the breast.XVIII. Effect of androstanediol dipropionate (5α-androstan-3α,17β-diol dipropionate) therapy on clinical course and hormonal excretion
Open Access
- 1 July 1961
- Vol. 14 (4) , 707-710
- https://doi.org/10.1002/1097-0142(199007/08)14:4<707::aid-cncr2820140406>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hormonal therapy in cancer of the breast.XVII. The effect of androsterone on clinical course and hormonal excretionCancer, 1960
- Hormonal therapy in cancer of the breast.XVI. The effect of Δ1-testololactone on clinical course and hormonal excretionCancer, 1960
- Δ1-Testololactone, Androsterone, and 5α-Androstane-3α, 17β-diol Dipropionate in the Treatment of Advanced Breast CancerPublished by Elsevier ,1960
- Testosterone Propionate Therapy of Breast Cancer—A Report for the Cooperative Breast Cancer GroupPublished by Elsevier ,1960
- Hormonal therapy in cancer of the breast.VIII. The effect of dihydrotestosterone (Androstanolone) on clinical course and hormonal excretionCancer, 1955
- Hormonal therapy in cancer of the breast.IX. The effect of androstanedione therapy on clinical course and hormonal excretionCancer, 1955